173 results on '"Whittle, Samuel L."'
Search Results
2. Methods for living guidelines: early guidance based on practical experience. Paper 2: consumer engagement in living guidelines
3. Crowdsourcing trainees in a living systematic review provided valuable experiential learning opportunities: a mixed-methods study
4. Equity Considerations in COVID‐19 Vaccination Studies of Individuals With Autoimmune Inflammatory Rheumatic Diseases
5. Using the derived 28-joint disease activity score patient-reported components (DAS28-P) index as a discriminatory measure of response to disease-modifying anti-rheumatic drug therapy in early rheumatoid arthritis
6. Industry involvement in rheumatology consensus-based recommendations: a systematic review
7. Crowdsourcing and automation facilitated the identification and classification of randomized controlled trials in a living review
8. Trajectories of self-reported pain-related health outcomes and longitudinal effects on medication use in rheumatoid arthritis: a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD)
9. Australian recommendations on perioperative use of disease‐modifying anti‐rheumatic drugs in people with inflammatory arthritis undergoing elective surgery
10. Prioritization of clinical questions for the Australian Living Guideline for the Pharmacological Management of Inflammatory Arthritis.
11. Which clinical research questions are the most important? Development and preliminary validation of the Australia & New Zealand Musculoskeletal (ANZMUSC) Clinical Trials Network Research Question Importance Tool (ANZMUSC-RQIT)
12. Vaccination Rates, Perceptions, and Information Sources Used by People With Inflammatory Arthritis
13. Equity Considerations in COVID‐19 Vaccination Studies of Individuals With Autoimmune Inflammatory Rheumatic Diseases
14. Australian recommendations on tapering of biologic and targeted synthetic disease‐modifying anti‐rheumatic drugs in inflammatory arthritis
15. Factors influencing clinician prescribing of disease-modifying anti-rheumatic drugs for inflammatory arthritis: A systematic review and thematic synthesis of qualitative studies
16. Gout prevalence and predictors of urate-lowering therapy use: results from a population-based study
17. Perioperative use of disease modifying anti-rheumatic drugs (DMARDs) in people with inflammatory arthritis
18. Consensus statements on the imaging of axial spondyloarthritis in Australia and New Zealand
19. DAS28-P Index as a Discriminatory Measure of Poor Subjective Response to Disease-Modifying Rheumatic Drug Therapy in Early Rheumatoid Arthritis
20. Dose reduction and discontinuation of disease-modifying anti-rheumatic drugs (DMARDs) for juvenile idiopathic arthritis
21. Isotretinoin-induced skeletal hyperostosis
22. Long-term glucocorticoids for rheumatoid arthritis
23. Industry involvement in rheumatology consensus-based recommendations: a systematic review
24. Dose reduction and discontinuation of biologic and targeted synthetic disease-modifying anti-rheumatic drugs (DMARDs) in people with axial spondyloarthritis and low disease activity
25. Short-term glucocorticoids for flares in people with rheumatoid arthritis receiving disease-modifying anti-rheumatic drugs (DMARDs)
26. Quality of reporting of interventional animal studies in rheumatology: a systematic review using the ARRIVE guidelines
27. Australian and New Zealand recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion in the 3e Initiative
28. COVID-19 vaccination for people with autoimmune inflammatory rheumatic diseases on immunomodulatory therapies
29. Consensus statement on the investigation and management of non-radiographic axial spondyloarthritis (nr-axSpA)
30. Perspectives of Glucocorticoid Use in Patients with Rheumatoid Arthritis
31. Measures of Adult Shoulder Function
32. Opioid Analgesics for Rheumatoid Arthritis Pain
33. Multinational evidence-based recommendations for pain management by pharmacotherapy in inflammatory arthritis: integrating systematic literature research and expert opinion of a broad panel of rheumatologists in the 3e Initiative
34. Active foot synovitis in patients with rheumatoid arthritis: Applying clinical criteria for disease activity and remission may result in underestimation of foot joint involvement
35. Disease-modifying anti-rheumatic drugs for rheumatoid arthritis: a systematic review and network meta-analysis
36. Marine oil supplements for rheumatoid arthritis
37. Tumour necrosis factor inhibitors and risk of serious infection in rheumatoid arthritis
38. Autologous blood product injections including platelet-rich plasma for osteoarthritis of the knee
39. Stem cell injections for osteoarthritis of the knee
40. The OMERACT Core Domain Set for Clinical Trials of Shoulder Disorders
41. Methotrexate for psoriatic arthritis
42. Early development of the Australia and New Zealand Musculoskeletal Clinical Trials Network.
43. Occipital condyle syndrome mimicking giant cell arteritis as the first manifestation of disseminated malignancy
44. Methotrexate for psoriatic arthritis
45. Consensus statements on the imaging of axial spondyloarthritis in Australia and New Zealand
46. Patients' experience of shoulder disorders: a systematic review of qualitative studies for the OMERACT Shoulder Core Domain Set.
47. Methotrexate for giant cell arteritis
48. Methotrexate for polymyalgia rheumatica
49. Update on the diagnosis and management of gout
50. Synovial fluid myeloid dendritic cells display important differences compared to monocyte-derived dendritic cells prepared in vitro
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.